Internal Medicine
Online ISSN : 1349-7235
Print ISSN : 0918-2918
ISSN-L : 0918-2918
CASE REPORTS
Switching from Insulin to Liraglutide Improved Glycemic Control and the Quality of Life Scores in a Case of Type 2 Diabetes and Active Crohn's Disease
Hirohito KuwataSatoru TsujiiNaotaka FujitaShintaro OkamuraTadao IburiTsuyoshi MashitaniMasako KitataniMiyuki FuruyaYasuaki HayashinoHitoshi Ishii
著者情報
ジャーナル オープンアクセス

2014 年 53 巻 15 号 p. 1637-1640

詳細
抄録
A 44-year-old man with type 2 diabetes of five years' duration was admitted for the management of poor glycemic control despite the administration of insulin therapy. On admission, he received vigorous treatment for a 28-year history of Crohn's disease and a 14-year history of a psychiatric disorder. His glycosylated hemoglobin A1c (HbA1c) level was 11.3%, his fasting blood glucose level was 567 mg/dL and his C-peptide level was 1.0 ng/mL. His quality of life (QOL) was severely impaired as a result of frequent episodes of hyperglycemia and hypoglycemia. Treatment with liraglutide was commenced in place of insulin, which improved the patient's glycemic control to an HbA1c level of 5.5% and markedly increased his QOL score with no hypoglycemia.
著者関連情報
© 2014 by The Japanese Society of Internal Medicine
前の記事 次の記事
feedback
Top